Camlin Fine Sciences Ltd (CAMLINFINE) Q4FY26 Management Mirror - Mar-2026 Qtr
Revenue & Margins
Management upgraded its FY27 revenue guidance to a range of INR 2,200 crores to INR 2,400 crores in the Mar'26 Qtr, rising from the Dec'25 Qtr expectation of approximately INR 2,200 crores (the Sep'25 Qtr had originally targeted FY26 revenue at INR 2,000 to INR 2,100 crores). The FY27 consolidated EBITDA margin guidance was consistently reaffirmed at 12% to 14% in both the Dec'25 Qtr and Mar'26 Qtr. [Status: Upgraded]
4 more themes on the ELITE plan.